From tumor immunophenotype analysis we interpreted that higher correlation of CDKN2 A and MUC5B to step 1, BIRC5 to step 2 while CCR9 to step 6 which means their up-regulation is associated with increased antigen recognition, antigen presentation and T cell activation. This evidence concerns the gene CDKN2A and neoplasm.